ArticleClinical transplantation2026
Predictive Value of HLA-Derived T-Cell Epitope and B-Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDonor/recipient HLA molecular mismatches are predictive of kidney transplant outcomes. Their role in pancreas transplantation has not been well studied.
methodsWe conducted a retrospective cohort study in 281 pancreas (± kidney) transplant recipients during 2000-2018, followed for average 53.8 months. T-cell epitope matching was performed by the PIRCHE-II algorithm (T2) and B-cell epitope mismatch using Snow (B2) and HLA Matchmaker algorithms. Primary outcome was pancreas acute rejection, secondary outcomes included pancreas graft failure and composite of both, and kidney graft failure.
resultsPIRCHE-T2 score (59.3±22.3) was not associated with study outcomes (HR 0.99, 95%CI 0.98-1.00, p = 0.31 for pancreas rejection). However, increasing PIRCHE-B score (15.1±6.3) was predictive of lower risk of acute rejection (aHR 0.94; 95%CI 0.9-0.99, p = 0.024) and graft failure (aHR 0.96; 95%CI 0.93-0.99; p = 0.021), driven by PIRCHE-B-Class II score (aHR 0.91; 95%CI 0.85-0.98, p = 0.01; aHR 0.92; 95%CI 0.88-0.97; p = 0.001, respectively). Total eplet mismatch (19.58±7.40) was highly correlated with PIRCHE-B score (ρ = 0.82, p < 0.0001), showing similar associations. However, the molecular scores were not associated with kidney graft failure (p > 0.57 for all).
conclusionOur study suggests that higher B-cell epitope mismatch loads are paradoxically associated with improved pancreas transplant outcomes, while PIRCHE-T2 scores demonstrated limited predictive value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.